In a move that further consolidates the CRO industry in China and the Far East, Chemizon, a division of Optomagic, and Crown Bioscience have formed a strategic alliance. As part of the alliance, Chemizon’s venture equity fund has participated in Crown Bioscience’s Series B round of financing. Both companies have labs in Asia, though their corporate homes are in the US. More details...

Stock Symbol: (KOSDAQ: 010170)